History

Distinctively re-engineer revolutionary meta-services and premium architectures. Intrinsically incubate intuitive opportunities and real-time potentialities. Appropriately communicate one-to-one technology after plug-and-play networks.

2018

August 2018

Kcat’s Inception in Paris in EuroSciCon

https://kcat.co.in/wp-content/uploads/2022/05/Picture1-768x512.jpg

Oct 4th, 2018

Started Office in Co-working space – 3 Founders, just 2 Interns, No Employees, No Projects

[bold_timeline_item_button title=”Expand” style=”” shape=”” color=”” size=”inline” url=”#” el_class=”bold_timeline_group_button”]

2019

March 2019

Our dedicated Computational facility in Cox Town from co-working space

Sep 2019

Kcat’s 7D Grid Technology was recognized as “Novel Tools in Enzyme Engineering” Enzyme Engg Consortium.

https://kcat.co.in/wp-content/uploads/2022/05/7D_Grid-768x596.png

Oct 2019

Pfizer visits Kcat’s Office in Cox Town

[bold_timeline_item_button title=”Expand” style=”” shape=”” color=”” size=”inline” url=”#” el_class=”bold_timeline_group_button”]

2020

March 2020

Kcat’s Molecular Biology Facility in Bangalore Bioinnovation Center

https://kcat.co.in/wp-content/uploads/2022/05/kcat_biotech_lab4-768x432.png

July 2020

Kcat received the Prestigious BIRAC BIG Grant from the Dept. of Biotechnology, India.

https://kcat.co.in/wp-content/uploads/2022/05/Birac-768x525.jpg

August 2020

Kcat receives 2 back-to-back UKRI Grants

https://kcat.co.in/wp-content/uploads/2022/05/UKRI-768x416.png
[bold_timeline_item_button title=”Expand” style=”” shape=”” color=”” size=”inline” url=”#” el_class=”bold_timeline_group_button”]

2021

Jan 2021

Building of Enzyme Libraries – Engineered  Enzyme Kits for diverse applications – Own Products

July 2021

 Hon’ble Finance Ministers Smt. Nirmala Seetharaman’s Visit

https://kcat.co.in/wp-content/uploads/2022/05/Nirma-768x512.jpg

August 2021

Established Fermentation Capabilities & gram scale protein production.

https://kcat.co.in/wp-content/uploads/2022/05/Fermentor.jpg

Sep 2021

Kcat releases 7 products – Engineered Enzyme Kits for diverse biocatalysis applications

https://kcat.co.in/wp-content/uploads/2022/06/histroy-1-1.png

Oct 2021

Supplied the Engineered Enzyme Kits to domestic and International Customers in Germany & UK

Oct 2021

Kcat received the Prestigious National Institute of Health (NIH) – USA

https://kcat.co.in/wp-content/uploads/2022/05/NIH-768x432.jpeg

Nov 2021

Signed Contracts for Enzyme Manufacturing & Continuous Supply of Enzymes

Dec 2021

Established manufacturing of Engineered Lipase through contract manufacturing mode at Kilogram scale.

Dec 2021

 Got some promising results in engineering flourinase – the toughest Enzyme Engineering Problem

[bold_timeline_item_button title=”Expand” style=”” shape=”” color=”” size=”inline” url=”#” el_class=”bold_timeline_group_button”]

2022

Jan 2022

KCAT Filed its First International Patent – 7D Grid & CRISPR Cas Technology

https://kcat.co.in/wp-content/uploads/2022/05/crisp2-768x432.png

Feb 2022

KCAT Published its research work in top journals in ACS Catalysis,  Catalysis Today, Journal of Biological Chemistry

https://kcat.co.in/wp-content/uploads/2022/05/Picture3-768x667.jpg

Mar 2022

Automated Lab for Enzyme Screening

April 2022

Kcat manuscript, “Structure dynamics and molecular inhibition of the Staphylococcus aureus m1A22-tRNA methyltransferase TrmK” has been selected as one of JBC’s “Editors Picks”.

https://kcat.co.in/wp-content/uploads/2022/06/histroy-2.jpg

May 2022

Kcat is once again recognized by the “Enzyme Engineering Consortium”.

Texas Dallas/Fort Worth

https://kcat.co.in/wp-content/uploads/2022/05/May2022-768x733.jpg
[bold_timeline_item_button title=”Expand” style=”” shape=”” color=”” size=”inline” url=”#” el_class=”bold_timeline_group_button”]

2023

March 2023

Kcat Enzymatic has successfully secured its first investment from Ideaspring Capital, marking a significant milestone in our journey towards creating a sustainable future for a more resilient tomorrow.

April 2023

We are extremely delighted to see you all at CPHI North America 2023. Come visit us at our booth #135.
Feel free to get in touch with us to discover how our state-of-the-art AI-powered technology can revolutionize your manufacturing process with novel biocatalytic routes.

October 2023

Our scientist Naveen, Gladstone & Pravin presenting the posters to Scientists at Enzyme Engineering Conference XXVII, Singapore-2023
#kcat #EEC #XXVII

[bold_timeline_item_button title=”Expand” style=”” shape=”” color=”” size=”inline” url=”#” el_class=”bold_timeline_group_button”]
Who is Amwerk?

A team of highly skilled manufacturers, prepared to meet any request for fabrication, tool crafting or product design and production.

Who is Amwerk?

A team of highly skilled manufacturers, prepared to meet any request for fabrication, tool crafting or product design and production.

Client Quotes

People tell it the bestQuotes

Year after year, multiple industries recognize Amwerk as a leader in quality, service, and innovation. We're proud to be one of the top custom solution manufacturers in the world.

Dramatically disseminate standardized metrics after resource-leveling processes. Objectively pursue diverse catalysts for change for services.

Michael Wright
Bello Servicing

Intrinsically incubate intuitive real time potentialities and opportunities communicate technology networks over time periods.

Daniel Huberth
Applauz

Globally harness multimedia based collaboration and idea-sharing with backend products opportunities via covalent scenarios.

John Strength
Avantage HR

Fabricate an expanded array of niche markets through robust products, implement visionary e-services vis-a-vis strategic readiness.

Mia McBride
Estato

Dramatically disseminate standardized metrics after resource-leveling processes. Objectively pursue diverse catalysts for change for services.

John Fox
Codiqa

Seamlessly empower fully researched growth strategies and interoperable internal or organic sources with optimal networks strategic web-readiness.

Hollie Neal
Nifty

Keeping your eye on the ball while performing a deep dive on the start-up mentality to derive convergence on cross-platform integration.

Elsie Moore
Konstrakt